255 related articles for article (PubMed ID: 33047268)
1. Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador.
Guevara-Aguirre J; Bautista C; Torres C; Peña G; Guevara C; Palacios C; Guevara A; Gavilanes AWD
Rev Endocr Metab Disord; 2021 Mar; 22(1):59-70. PubMed ID: 33047268
[TBL] [Abstract][Full Text] [Related]
2. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
3. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.
Rosenbloom AL
Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451
[TBL] [Abstract][Full Text] [Related]
4. Despite higher body fat content, Ecuadorian subjects with Laron syndrome have less insulin resistance and lower incidence of diabetes than their relatives.
Guevara-Aguirre J; Procel P; Guevara C; Guevara-Aguirre M; Rosado V; Teran E
Growth Horm IGF Res; 2016 Jun; 28():76-8. PubMed ID: 26259979
[TBL] [Abstract][Full Text] [Related]
5. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone (GH) insensitivity and insulin-like growth factor-I deficiency in Inuit subjects and an Ecuadorian cohort: functional studies of two codon 180 GH receptor gene mutations.
Fang P; Girgis R; Little BM; Pratt KL; Guevara-Aguirre J; Hwa V; Rosenfeld RG
J Clin Endocrinol Metab; 2008 Mar; 93(3):1030-7. PubMed ID: 18073295
[TBL] [Abstract][Full Text] [Related]
7. Laron syndrome - A historical perspective.
Laron Z; Werner H
Rev Endocr Metab Disord; 2021 Mar; 22(1):31-41. PubMed ID: 32964395
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations.
Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Diamond FB; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Feb; 76(2):417-23. PubMed ID: 7679400
[TBL] [Abstract][Full Text] [Related]
9. Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients-From discovery to treatment.
Laron Z; Kauli R
Growth Horm IGF Res; 2016 Jun; 28():53-6. PubMed ID: 26307357
[TBL] [Abstract][Full Text] [Related]
10. Cancer in Ecuadorian subjects with Laron syndrome (ELS).
Guevara-Aguirre J; Peña G; Pazmiño G; Acosta W; Saavedra J; Lescano D; Guevara A; Gavilanes AWD
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36971780
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.
Janecka A; Kołodziej-Rzepa M; Biesaga B
In Vivo; 2016; 30(4):375-81. PubMed ID: 27381597
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034
[TBL] [Abstract][Full Text] [Related]
13. Novel growth hormone receptor mutation in a Chinese patient with Laron syndrome.
Hui HN; Metherell LA; Ng KL; Savage MO; Camacho-Hübner C; Clark AJ
J Pediatr Endocrinol Metab; 2005 Feb; 18(2):209-13. PubMed ID: 15751611
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence.
Somri L; Sarfstein R; Lapkina-Gendler L; Nagaraj K; Laron Z; Bach LA; Werner H
Growth Horm IGF Res; 2018 Apr; 39():6-12. PubMed ID: 29208357
[TBL] [Abstract][Full Text] [Related]
15. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
[TBL] [Abstract][Full Text] [Related]
16. Novel growth hormone receptor gene mutation in a patient with Laron syndrome.
Arman A; Yüksel B; Coker A; Sarioz O; Temiz F; Topaloglu AK
J Pediatr Endocrinol Metab; 2010 Apr; 23(4):407-14. PubMed ID: 20583548
[TBL] [Abstract][Full Text] [Related]
17. Fanconi Anemia and Laron Syndrome.
Castilla-Cortazar I; de Ita JR; Aguirre GA; Castorena-Torres F; Ortiz-Urbina J; García-Magariño M; de la Garza RG; Diaz Olachea C; Elizondo Leal MI
Am J Med Sci; 2017 May; 353(5):425-432. PubMed ID: 28502327
[TBL] [Abstract][Full Text] [Related]
18. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
[TBL] [Abstract][Full Text] [Related]
19. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree.
Silbergeld A; Dastot F; Klinger B; Kanety H; Eshet R; Amselem S; Laron Z
J Pediatr Endocrinol Metab; 1997; 10(3):265-74. PubMed ID: 9388817
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]